For patients living with currently untreatable and life-limiting conditions, cell and gene therapies (CGTs) represent an exciting possibility — the possibility of effective treatments or even cures; offering the chance to live healthier, longer lives. It is no surprise, then, that the global CGT market is booming. In 2023 alone, the market was valued at USD 9.95 billion, and it is anticipated to expand to USD 106.03 billion by 2033.
read more